Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04678362
Title TALazoparib and Avelumab as Maintenance Therapy in Platinum-Sensitive Metastatic or Locally Advanced URothelial Carcinoma (TALASUR)
Acronym TALASUR
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Centre Francois Baclesse
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA


No variant requirements are available.